Verastem, Inc. (VSTM): Stock Offering News

VSTM – Announces commencement of $35 mln common stock offering.


Key Facts Surrounding This News Item


  • VSTM had a POWR Rating of B (Buy) coming into today.
  • VSTM was 16.57% above its 10-Day Moving Average coming into today.
  • VSTM was 19.41% above its 20-Day Moving Average coming into today.
  • VSTM was 38.89% above its 50-Day Moving Average coming into today.
  • VSTM was 48.99% above its 100-Day Moving Average coming into today.
  • VSTM was 38.70% above its 200-Day Moving Average coming into today.
  • VSTM had returned +67.75% year-to-date leading up to today’s news, versus a +2.70% return from the benchmark S&P 500 during the same period.

More Info About Verastem, Inc. (VSTM)


Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts. View our full VSTM ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

VSTM at a Glance

VSTM Current POWR Rating™
Overall POWR Rating™
VSTM Current Price $8.26 0.24%
More VSTM Ratings, Data, and News

VSTM Price Reaction

The day of this event (May. 15, 2018)
VSTM Closing Price$5.24 1.75%
VSTM Volume1,225,500
24.19% from avg
Leading up to this event
VSTM 1-mo returnN/A%
After this event
VSTM 1-day return11.71%
VSTM 3-day return2.59%
VSTM 5-day return3.20%

VSTM Price Chart



More Verastem, Inc. (VSTM) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VSTM News
Page generated in 1.208 seconds.